United States · FDA National Drug Code directory
AVTOZMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72606-045_31d10ad3-79c2-4464-a454-a7eee4eb4b5d
- Product NDC
- 72606-045
- Form
- INJECTION, SOLUTION
- Composition / generic term
- tocilizumab
- Labeler
- CELLTRION USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260201
- Source listing expiry
- 20271231
Source-listed ingredients
- TOCILIZUMAB — 162 mg/.9mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (72606-045-01) / .9 mL in 1 SYRINGE, GLASS · 72606-045-01
- 4 SYRINGE, GLASS in 1 CARTON (72606-045-02) / .9 mL in 1 SYRINGE, GLASS · 72606-045-02
- 12 SYRINGE, GLASS in 1 CARTON (72606-045-03) / .9 mL in 1 SYRINGE, GLASS · 72606-045-03
- 1 SYRINGE, GLASS in 1 CARTON (72606-045-04) / .9 mL in 1 SYRINGE, GLASS · 72606-045-04
- 4 SYRINGE, GLASS in 1 CARTON (72606-045-05) / .9 mL in 1 SYRINGE, GLASS · 72606-045-05
- 12 SYRINGE, GLASS in 1 CARTON (72606-045-06) / .9 mL in 1 SYRINGE, GLASS · 72606-045-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →